INKT Chart
- 52-Week Range: $1.19 - $3.61
- Market Capitalization: $75.68M
- Short Percentage: 0%
- Target Price: $7.75
- Shares Outstanding: 33.78M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
No upcoming catalysts found
News and Press Releases
- MiNK Therapeutics to Participate in B. Riley Securities Oncology ConferenceGlobeNewsWire | January 11th
- MiNK Therapeutics to Participate in Evercore ISI HealthCONx ConferenceGlobeNewsWire | November 17th
- MiNK Presents Clinical Data at SITC 2022 Showcasing iNKT Cell Therapy PipelineGlobeNewsWire | November 10th
- MiNK Therapeutics Reports Corporate Update and Third Quarter 2022 Financial ResultsGlobeNewsWire | November 3rd
- MiNK Therapeutics to Report Third Quarter 2022 Financial Results and Business UpdateGlobeNewsWire | October 20th
- MiNK Selected for Five Presentations at Society for Immunotherapy of Cancer's (SITC) 37th Annual MeetingGlobeNewsWire | October 5th
- MiNK Therapeutics, Inc.'s (INKT) CEO Jennifer Buell on Q2, 2022 Results.Seeking Alpha | August 13th
- MiNK Therapeutics Reports Corporate Update and Second Quarter 2022 Financial ResultsGlobeNewsWire | August 9th
- MiNK Therapeutics to Report Second Quarter 2022 Financial Results and Business UpdateGlobeNewsWire | July 27th
Company Info
Website: https://minktherapeutics.com
Address: 149 Fifth Avenue, New York, NY, United States, 10010
Sector: Healthcare
Industry: Biotechnology
Full time employees: 33
Address: 149 Fifth Avenue, New York, NY, United States, 10010
Sector: Healthcare
Industry: Biotechnology
Full time employees: 33
$INKT pump up the volume
$INKT f this stock
$INKT Shorts are calling in all the favors
$INKT has just been halted from trading due to volatility.
$INKT has just been halted from trading due to volatility.
$INKT Dip buyers are going to get wrecked
$INKT very normal lol sike
$INKT Just buy and hold
$INKT Holding
$INKT still bullish